BA
BIOA

BlackRock Advisors’s BioAmber Inc. BIOA Stock Holding History

BlackRock Advisors’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1,164
Closed -$13K – 3748
2014
Q1 		$13K Buy
+1,164
New +$13.8K ﹤0.01% 3508

Other funds holding BIOA

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
ACPU
Arrowgrass Capital Partners (US) Dover, Delaware $380M AUM 20.87% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NIMI
Natixis Investment Managers International Paris, France $1.29B AUM 24.83% 1-Year Est. Return

BlackRock Advisors's BIOA Position: Q2 2014 in Review

BlackRock Advisors sold out of BioAmber Inc. (BIOA) in Q2 2014, closing a stake of 1,164 shares — an estimated $13K sold.

BlackRock Advisors first reported a position in BIOA in Q1 2014 and held it in 1 quarter. The position peaked at $13K in Q1 2014. 24 funds tracked by Wall St. Rank hold BIOA as of Q2 2014.

  • BlackRock Advisors reported no remaining BioAmber Inc. position as of Q2 2014 after selling out during the quarter.
  • BlackRock Advisors sold 1,164 BioAmber Inc. shares in Q2 2014, an estimated $13K.
  • BlackRock Advisors first reported a position in BioAmber Inc. in Q1 2014 and held it in 1 quarter.
  • BlackRock Advisors's BioAmber Inc. position peaked at $13K in Q1 2014.
  • 24 funds tracked by Wall St. Rank held BioAmber Inc. as of Q2 2014.

Based on BlackRock Advisors's 13F filing for Q2 2014, filed 6 Aug 2014.